Showing results (841-850 of 936) with videos related to

Sort By:
Pageof 94
Nature Communications|October 18, 2023
Infection- or AZD1222 vaccine-mediated immunity reduces SARS-CoV-2 transmission but increases Omicron competitiveness in hamstersJulia R Port, Claude Kwe Yinda, Jade C Riopelle, et al.
Ebiomedicine|February 8, 2025
A phase 1b clinical trial to determine the safety, tolerability and immunogenicity of simian adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies in patients with active Crohn's diseaseJeremy Sanderson, Jeremy Aboagye, Rebecca Makinson, et al.
Public Health Nutrition|July 10, 2007
Assessing, understanding and modifying nutritional status, eating habits and physical activity in European adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) StudyL A Moreno, M González-Gross, M Kersting, et al.
The Journal of Infectious Diseases|April 11, 2013
Comparison of modeling methods to determine liver-to-blood inocula and parasite multiplication rates during controlled human malaria infectionAlexander D Douglas, Nick J Edwards, Christopher J A Duncan, et al.
Public Health Nutrition|February 22, 2012
Breakfast habits among European adolescents and their association with sociodemographic factors: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) studyLena Hallström, Carine A Vereecken, Idoia Labayen, et al.
The Lancet. Infectious Diseases|April 15, 2023
Safety and immunogenicity of a ChAdOx1 vaccine against Rift Valley fever in UK adults: an open-label, non-randomised, first-in-human phase 1 clinical trialDaniel Jenkin, Daniel Wright, Pedro M Folegatti, et al.
Scientific Reports|April 24, 2013
The utility of Plasmodium berghei as a rodent model for anti-merozoite malaria vaccine assessmentAnna L Goodman, Emily K Forbes, Andrew R Williams, et al.
Med (New York, N.Y.)|February 1, 2021
A booster dose enhances immunogenicity of the COVID-19 vaccine candidate ChAdOx1 nCoV-19 in aged miceAlyssa Silva-Cayetano, William S Foster, Silvia Innocentin, et al.
Biotechnology and Bioengineering|July 13, 2022
Production of a high purity, C-tagged hepatitis B surface antigen fusion protein VLP vaccine for malaria expressed in Pichia pastoris under cGMP conditionsEkta Mukhopadhyay, Florian Brod, Philip Angell-Manning, et al.
Plos One|April 16, 2009
MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaquesFrank A W Verreck, Richard A W Vervenne, Ivanela Kondova, et al.
Pageof 94